Expressions of Telomerase Reverse Transcriptase and Heparanase in Prognosis of Patients with Colorectal Cancer
10.3321/j.issn:1000-467X.2001.06.014
- VernacularTitle:结肠直肠癌端粒酶、肝素酶表达升高与预后的关系
- Author:
Po ZHAO
1
;
Ya-Li LU
;
Mei ZHONG
;
Dian-Jun WANG
Author Information
1. General Hospital of People's Liberation Army
- From:Chinese Journal of Cancer
2001;20(6):624-627
- CountryChina
- Language:Chinese
-
Abstract:
Objective：The aim of this study was to investigate the relationship among the telomerase reverse transcriptase (TRT), the heparanase gene expressions, and the metastasis and prognosis of colorectal cancer. Method： The expression of TRT in 33 cases of formalin fixed, paraffin embedded colorectal adenocarcinoma tissues was examined using antibody of human TRT and Streptavidin HRP(SP) immunohistochemical method, meanwhile metastasis and 5 year survival rate of the patients were analyzed. The expression of heparanase gene in tweenty fresh colorectal carcinoma tissues were also analyzed by reverse transcriptase polymerase chain reaction (RT PCR). Results： The expression of TRT was found positive in all 33 patients with colorectal cancer, of which 14 cases were strongly positive and 19 weakly positive. TRT was expressed diffusely in the cytoplasm and partly in the nuclei of the cancer cells. Whereas only minimally or weakly positive signals for TRT located mainly in the nuclei with few cytoplasm around, were found in normal or in proliferative colorectal mucosa. The metastatic rate and the 5 year survival rate in tumors with strong expressing TRT were 50.0％ (7/14) and 21.4％ (3/14), respectively, whereas in those with weak expressing TRT were 15.8％ (3/19) and 84.2％ (16/19), respectively. There were significant differences between two groups in the metastatic rate (P< 0.05) and the 5 year survival rate (P < 0.001).The expression of heparanase gene was found positive in 20/20 cases of colorectal carcinoma when RT PCR using 0.5 μ g total RNA but positive was only in 11/20 cases of the cancer when using 0.1 μ g total RNA. The positive rate for metastatic tumors was 90.0％ (9/10), whereas for non metastatic tumors it was only 20.0％ (2/10) when using 0.1 μ g templet of total RNA. Five cases of normal colorectal mucosa were negative for heparanase. Conclusions： The expression of TRT may be corresponding to metastatic rate and 5 year survival rate. The expression of heparanase gene may be related to the malignant degree and metastasis of colorectal cancer. Both TRT and heparanase may be important new markers for predicting the prognosis of the patients with colorectal cancer.
